Skip to main content
Top
Published in: Tumor Biology 5/2012

01-10-2012 | Research Article

Opposite roles of LPA1 and LPA3 on cell motile and invasive activities of pancreatic cancer cells

Authors: Kohei Kato, Kyohei Yoshikawa, Eriko Tanabe, Misaho Kitayoshi, Rie Fukui, Nobuyuki Fukushima, Toshifumi Tsujiuchi

Published in: Tumor Biology | Issue 5/2012

Login to get access

Abstract

Lysophosphatidic acid (LPA) interacts with at least six G protein-coupled transmembrane LPA receptors. Recently, it has been demonstrated that each LPA receptor acts as a positive or negative regulator of cellular function. In the present study, to assess a biological role of LPA receptors on cell migration of pancreatic cancer cells, we generated LPA receptor-1 (LPA1) and LPA3 knockdown cells from hamster pancreatic cancer cells by transfection with short hairpin RNA plasmids and measured their cell motile and invasive abilities. In cell motility and invasion assay, a Cell Culture Insert, coated with or without a Matrigel, was used. While the cell motility and invasion of Lpar1 knockdown cells were markedly enhanced than those of control cells, Lpar3 knockdown cells showed significantly lower cell motility and invasion. Moreover, to investigate an involvement of LPA1 and LPA3 in the development of pancreatic cancers, we also measured the expression levels of Lpar1 and Lpar3 genes in hamster pancreatic duct adenocarcinomas (PDAs) induced by a nitroso compound. The expressions of Lpar1 gene in PDAs were significantly lower than those in normal pancreatic tissues. By contrast, the elevated expressions of Lpar3 gene were detected in PDAs. We thus demonstrate that LPA1 and LPA3 play the different roles on cell migration ability of pancreatic cancer cells, suggesting the opposite effects via LPA1 and LPA3 may contribute to the pathogenesis of pancreatic cancers in hamsters.
Literature
1.
go back to reference Contos JJA, Ishii I, Chun J. Lysophosphatidic acid receptors. Mol Pharmacol. 2000;58:1188–96.PubMed Contos JJA, Ishii I, Chun J. Lysophosphatidic acid receptors. Mol Pharmacol. 2000;58:1188–96.PubMed
2.
go back to reference Ishii I, Fukushima N, Ye X, Chun J. Lysophospholipid receptors: signaling and biology. Annu Rev Biochem. 2004;73:321–54.CrossRefPubMed Ishii I, Fukushima N, Ye X, Chun J. Lysophospholipid receptors: signaling and biology. Annu Rev Biochem. 2004;73:321–54.CrossRefPubMed
3.
go back to reference Lin M-E, Herr DR, Chun J. Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance. Prostaglandins Other Lipid Mediat. 2010;91:130–38.CrossRefPubMedPubMedCentral Lin M-E, Herr DR, Chun J. Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance. Prostaglandins Other Lipid Mediat. 2010;91:130–38.CrossRefPubMedPubMedCentral
4.
go back to reference Shida D, Watanabe T, Aoki A, Hama K, Kitayama J, Sonoda H, Kishi Y, Yamaguchi H, Sasaki S, Sako A, Konishi T, Arai H, Nagawa H. Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer. Lab Investig. 2004;84:1352–62.CrossRefPubMed Shida D, Watanabe T, Aoki A, Hama K, Kitayama J, Sonoda H, Kishi Y, Yamaguchi H, Sasaki S, Sako A, Konishi T, Arai H, Nagawa H. Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer. Lab Investig. 2004;84:1352–62.CrossRefPubMed
5.
go back to reference Furui T, LaPushin R, Mao M, Khan H, Watt SR, Watt MAV. Overexpression of Edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner. Clin Cancer Res. 1999;5:4308–18.PubMed Furui T, LaPushin R, Mao M, Khan H, Watt SR, Watt MAV. Overexpression of Edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner. Clin Cancer Res. 1999;5:4308–18.PubMed
6.
go back to reference Panupinthu N, Lee HY, Mills GB. Lysophosphatidic acid production and action: critical new plays in breast cancer initiation and progression. Br J Cancer. 2010;102:941–46.CrossRefPubMedPubMedCentral Panupinthu N, Lee HY, Mills GB. Lysophosphatidic acid production and action: critical new plays in breast cancer initiation and progression. Br J Cancer. 2010;102:941–46.CrossRefPubMedPubMedCentral
7.
go back to reference Tsujino M, Fujii M, Okabe K, Mori T, Fukushima N, Tsujiuchi T. Differential expressions and DNA methylation patterns of lysophosphatidic acid receptor genes in human colon cancer cells. Virchows Arch. 2010;457:669–76.CrossRefPubMed Tsujino M, Fujii M, Okabe K, Mori T, Fukushima N, Tsujiuchi T. Differential expressions and DNA methylation patterns of lysophosphatidic acid receptor genes in human colon cancer cells. Virchows Arch. 2010;457:669–76.CrossRefPubMed
8.
go back to reference Tsujiuchi T, Shimizu K, Onishi M, Sugata E, Fujii H, Mori T, Honoki K, Fukushima N. Involvement of aberrant DNA methylation on reduced expression of lysophosphatidic acid receptor-1 gene in rat tumor cell lines. Biochem Biophys Res Commun. 2006;349:1151–55.CrossRefPubMed Tsujiuchi T, Shimizu K, Onishi M, Sugata E, Fujii H, Mori T, Honoki K, Fukushima N. Involvement of aberrant DNA methylation on reduced expression of lysophosphatidic acid receptor-1 gene in rat tumor cell lines. Biochem Biophys Res Commun. 2006;349:1151–55.CrossRefPubMed
9.
go back to reference Okabe K, Hayashi M, Wakabayashi N, Yamawaki Y, Teranishi M, Fukushima N, Tsujiuchi T. Different expressions and DNA methylation patterns of lysophosphatidic acid receptor genes in mouse tumor cells. Pathobiology. 2010;77:309–14.CrossRefPubMed Okabe K, Hayashi M, Wakabayashi N, Yamawaki Y, Teranishi M, Fukushima N, Tsujiuchi T. Different expressions and DNA methylation patterns of lysophosphatidic acid receptor genes in mouse tumor cells. Pathobiology. 2010;77:309–14.CrossRefPubMed
10.
go back to reference Edwards BK, Brown MI, Wingo PA, Howe H, Ward E, Ries LA, Schrag D, Jamison PM, Jemal A, Wu XC, Friedman C, Harlan L, Warren J, Anderson RN, Pickle LW. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst. 2005;97:1407–27.CrossRefPubMed Edwards BK, Brown MI, Wingo PA, Howe H, Ward E, Ries LA, Schrag D, Jamison PM, Jemal A, Wu XC, Friedman C, Harlan L, Warren J, Anderson RN, Pickle LW. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst. 2005;97:1407–27.CrossRefPubMed
11.
go back to reference Tsujiuchi T, Furukawa M, Yamasaki A, Hotta M, Kusunoki C, Suyama N, Mori T, Honoki K, Fukushima N. Infrequent mutation of lysophosphatidic acid receptor-1 gene in hamster pancreatic duct adenocarcinomas and established cell lines. J Toxicol Pathol. 2009;22:89–92.CrossRefPubMedPubMedCentral Tsujiuchi T, Furukawa M, Yamasaki A, Hotta M, Kusunoki C, Suyama N, Mori T, Honoki K, Fukushima N. Infrequent mutation of lysophosphatidic acid receptor-1 gene in hamster pancreatic duct adenocarcinomas and established cell lines. J Toxicol Pathol. 2009;22:89–92.CrossRefPubMedPubMedCentral
12.
go back to reference Mori T, Tsutsumi M, Noguchi O, Horiguchi K, Honoki K, Okita S, Suzuki F, Konishi Y. Characterization of three cloned cell lines from N-nitrosobis(2-oxopropyl)amine induced transplantable hamster pancreatic ductal adenocarcinoma. Int J Pancreatol. 1994;16:171–7.PubMed Mori T, Tsutsumi M, Noguchi O, Horiguchi K, Honoki K, Okita S, Suzuki F, Konishi Y. Characterization of three cloned cell lines from N-nitrosobis(2-oxopropyl)amine induced transplantable hamster pancreatic ductal adenocarcinoma. Int J Pancreatol. 1994;16:171–7.PubMed
13.
go back to reference Mizumoto K, Tsutsumi M, Denda A, Konishi Y. Rapid production of pancreatic carcinoma by initiation with N-nitrosobis(2-oxopropyl)amine and repeated augmentation pressure in hamsters. J Natl Cancer Inst. 1988;80:1564–7.CrossRefPubMed Mizumoto K, Tsutsumi M, Denda A, Konishi Y. Rapid production of pancreatic carcinoma by initiation with N-nitrosobis(2-oxopropyl)amine and repeated augmentation pressure in hamsters. J Natl Cancer Inst. 1988;80:1564–7.CrossRefPubMed
14.
go back to reference Okabe K, Kato K, Teranishi M, Okumura M, Fukui R, Mori T, Fukushima N, Tsujiuchi T. Induction of lysophosphatidic acid receptor-3 by 12-O-tetradecanoylphorbol-13-acetate stimulates cell migration of rat liver cells. Cancer Lett. 2011;309:236–42.CrossRefPubMed Okabe K, Kato K, Teranishi M, Okumura M, Fukui R, Mori T, Fukushima N, Tsujiuchi T. Induction of lysophosphatidic acid receptor-3 by 12-O-tetradecanoylphorbol-13-acetate stimulates cell migration of rat liver cells. Cancer Lett. 2011;309:236–42.CrossRefPubMed
15.
go back to reference Shano S, Hatanaka K, Ninose S, Moriyama R, Tsujiuchi T, Fukushima N. A lysophosphatidic acid receptor lacking the PDZ-binding domain is constitutively active and stimulates cell proliferation. Biochem Biophys Acta. 2008;1783:748–59.CrossRefPubMed Shano S, Hatanaka K, Ninose S, Moriyama R, Tsujiuchi T, Fukushima N. A lysophosphatidic acid receptor lacking the PDZ-binding domain is constitutively active and stimulates cell proliferation. Biochem Biophys Acta. 2008;1783:748–59.CrossRefPubMed
16.
go back to reference Okabe K, Hayashi M, Yamawaki Y, Teranishi M, Honoki K, Mori T, Fukushima N, Tsujiuchi T. Possible involvement of lysophosphatidic acid receptor-5 gene in the acquisition of growth advantage of rat tumor cells. Mol Carcinog. 2011;50:635–42.CrossRefPubMed Okabe K, Hayashi M, Yamawaki Y, Teranishi M, Honoki K, Mori T, Fukushima N, Tsujiuchi T. Possible involvement of lysophosphatidic acid receptor-5 gene in the acquisition of growth advantage of rat tumor cells. Mol Carcinog. 2011;50:635–42.CrossRefPubMed
17.
go back to reference Kato K, Fukui R, Okabe K, Tanabe E, Kitayoshi M, Fukushima N, Tsujiuchi T. Constitutively active lysophosphatidic acid receptor-1 enhances the induction of matrix metalloproteinase-2. Biochem Biophys Res Commun. 2012;417:790–93.CrossRefPubMed Kato K, Fukui R, Okabe K, Tanabe E, Kitayoshi M, Fukushima N, Tsujiuchi T. Constitutively active lysophosphatidic acid receptor-1 enhances the induction of matrix metalloproteinase-2. Biochem Biophys Res Commun. 2012;417:790–93.CrossRefPubMed
18.
go back to reference Chen P, Parks WC. Role of matrix metalloproteinases in epithelial migration. J Cell Biochem. 2009;108:1233–43.CrossRefPubMed Chen P, Parks WC. Role of matrix metalloproteinases in epithelial migration. J Cell Biochem. 2009;108:1233–43.CrossRefPubMed
20.
go back to reference Hayashi M, Okabe K, Kato K, Okumura M, Fukui R, Honoki K, Fukushima N, Tsujiuchi T. Differential function of lysophosphatidic acid receptors in cell proliferation and migration of neuroblastoma cells. Cancer Lett. 2012;316:91–6.CrossRefPubMed Hayashi M, Okabe K, Kato K, Okumura M, Fukui R, Honoki K, Fukushima N, Tsujiuchi T. Differential function of lysophosphatidic acid receptors in cell proliferation and migration of neuroblastoma cells. Cancer Lett. 2012;316:91–6.CrossRefPubMed
21.
go back to reference Shida D, Kitayama J, Yamaguchi H, Hama K, Aoki J, Arai H, Yamashita H, Mori K, Sako A, Konishi T, Watanabe T, Sakai T, Suzuki R, Ohta H, Takuwa Y, Nagawa H. Dual mode regulation of migration by lysophosphatidic acid in human gastric cancer cells. Exp Cell Res. 2004;301:168–78.CrossRefPubMed Shida D, Kitayama J, Yamaguchi H, Hama K, Aoki J, Arai H, Yamashita H, Mori K, Sako A, Konishi T, Watanabe T, Sakai T, Suzuki R, Ohta H, Takuwa Y, Nagawa H. Dual mode regulation of migration by lysophosphatidic acid in human gastric cancer cells. Exp Cell Res. 2004;301:168–78.CrossRefPubMed
22.
go back to reference Shida D, Kitayama J, Yanaguchi H, Okaji Y, Tsuno NH, Watanabe T, Takuwa Y, Nagawa H. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1. Cancer Res. 2003;63:1706–11.PubMed Shida D, Kitayama J, Yanaguchi H, Okaji Y, Tsuno NH, Watanabe T, Takuwa Y, Nagawa H. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1. Cancer Res. 2003;63:1706–11.PubMed
23.
go back to reference Yu S, Murph MM, Lu Y, Liu S, Hall HS, Liu J, Stephens C, Fang X, Mills GB. Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells. J Natl Cancer Inst. 2008;100:1630–42.CrossRefPubMedPubMedCentral Yu S, Murph MM, Lu Y, Liu S, Hall HS, Liu J, Stephens C, Fang X, Mills GB. Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells. J Natl Cancer Inst. 2008;100:1630–42.CrossRefPubMedPubMedCentral
24.
go back to reference Okabe K, Hayashi M, Kato K, Okumura M, Fukui R, Honoki K, Fukushima N, Tsujiuchi T. Lysophosphatidic acid receptor-3 increases tumorigenicity and aggressiveness of rat hepatoma RH7777 cells. Mol Carcinog. 2012. doi:10.1002/mc.21851. Okabe K, Hayashi M, Kato K, Okumura M, Fukui R, Honoki K, Fukushima N, Tsujiuchi T. Lysophosphatidic acid receptor-3 increases tumorigenicity and aggressiveness of rat hepatoma RH7777 cells. Mol Carcinog. 2012. doi:10.​1002/​mc.​21851.
25.
go back to reference Hayashi M, Okabe K, Yamawaki Y, Teranishi M, Honoki K, Mori T, Fukushima N, Tsujiuchi T. Loss of lysophosphatidic acid receptor-3 enhances cell migration in rat lung tumor cells. Biochem Biophys Res Commun. 2011;405:450–4.CrossRefPubMed Hayashi M, Okabe K, Yamawaki Y, Teranishi M, Honoki K, Mori T, Fukushima N, Tsujiuchi T. Loss of lysophosphatidic acid receptor-3 enhances cell migration in rat lung tumor cells. Biochem Biophys Res Commun. 2011;405:450–4.CrossRefPubMed
26.
go back to reference Park SY, Jeong KJ, Panupinthu N, Yu S, Lee J, Han JW, Kim JM, Lee J-S, Kang J, Park CG, Mills GB, Lee HY. Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression. Oncogene. 2011;30:1351–9.CrossRefPubMed Park SY, Jeong KJ, Panupinthu N, Yu S, Lee J, Han JW, Kim JM, Lee J-S, Kang J, Park CG, Mills GB, Lee HY. Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression. Oncogene. 2011;30:1351–9.CrossRefPubMed
27.
go back to reference Zaslavsky A, Singh LS, Tan H, Ding H, Liang Z, Xu Y. Homo- and hetero-dimerization of LPA/SIP receptors, OGR1 and GPR4. Biochem Biophys Acta. 2006;1761:1200–12.PubMed Zaslavsky A, Singh LS, Tan H, Ding H, Liang Z, Xu Y. Homo- and hetero-dimerization of LPA/SIP receptors, OGR1 and GPR4. Biochem Biophys Acta. 2006;1761:1200–12.PubMed
Metadata
Title
Opposite roles of LPA1 and LPA3 on cell motile and invasive activities of pancreatic cancer cells
Authors
Kohei Kato
Kyohei Yoshikawa
Eriko Tanabe
Misaho Kitayoshi
Rie Fukui
Nobuyuki Fukushima
Toshifumi Tsujiuchi
Publication date
01-10-2012
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 5/2012
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-012-0433-0

Other articles of this Issue 5/2012

Tumor Biology 5/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine